 | Inhibrx's (INBX) Buy Rating Reaffirmed at JMP Securities
marketbeat.com - October 13 at 12:32 PM |
 | Inhibrx (NASDAQ:INBX) Shares Up 6.7%
americanbankingnews.com - October 13 at 1:46 PM |
| Inhibrx (NASDAQ:INBX) Stock Rating Reaffirmed by JMP Securities
americanbankingnews.com - October 13 at 12:26 PM |
 | 30 Stocks Moving In Tuesday's Mid-Day Session
finance.yahoo.com - October 12 at 5:34 PM |
| INBRX-101 Shows Favorable Safety Profile in Patients with Alpha-1 Antitrypsin Deficiency and Demonstrates the Potential to Achieve Normal Alpha-1 Antitrypsin Levels with Monthly Dosing
finance.yahoo.com - October 12 at 12:32 PM |
| Here's Why Inhibrx Stock Is on the Move Today
finance.yahoo.com - October 12 at 12:32 PM |
| Inhibrx (NASDAQ:INBX) Shares Gap Up to $27.61
americanbankingnews.com - October 12 at 10:52 AM |
| Inhibrx (NASDAQ:INBX) Shares Gap Up to $31.14
americanbankingnews.com - October 5 at 12:22 PM |
| Inhibrx (NASDAQ:INBX) Shares Gap Down to $36.77
americanbankingnews.com - September 28 at 11:14 AM |
 | Inhibrx Inc.
barrons.com - August 26 at 9:37 PM |
| The Inhibrx, Inc. (NASDAQ:INBX) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
finance.yahoo.com - August 12 at 3:57 PM |
| Inhibrx Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 9 at 6:45 PM |
|
 | Inhibrx Launches Mid-Stage Bone Cancer Study With INBRX-109, Amends Loan Agreement With Oxford
markets.businessinsider.com - June 22 at 8:08 AM |
 | BRIEF-Inhibrx Initiates Potential Registration-Enabling Phase 2 Study Of Inbrx-109
msn.com - June 21 at 7:36 PM |
| Inhibrx Initiates a Potential Registration-Enabling Phase 2 Study of INBRX-109 in Conventional Chondrosarcoma Patients, Updates Data for Ongoing Phase 1 Study and Announces Amended Loan Agreement with Oxford
finance.yahoo.com - June 21 at 7:36 PM |
| Inhibrx Announces Participation in Upcoming Investor Conferences
finance.yahoo.com - May 17 at 7:25 PM |
 | Earnings Update: Inhibrx, Inc. (NASDAQ:INBX) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
nasdaq.com - May 16 at 1:43 PM |
| Inhibrx Reports First Quarter 2021 Financial Results
finance.yahoo.com - May 13 at 11:01 PM |
| Inhibrx Surpasses 4Q Revenue Estimates; Street Remains Bullish
finance.yahoo.com - March 14 at 9:13 AM |
| Inhibrx's INBRX-105 Shows Dose-Limiting Toxicities In Early-Stage Solid Tumors Study
markets.businessinsider.com - March 12 at 9:12 PM |
| Inhibrx Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Announces Phase 1 Single Agent Dose Escalation Results for INBRX-105, a Novel Targeted 4-1BB Agonist
finance.yahoo.com - March 12 at 9:12 PM |
| Inhibrx Announces Participation in Upcoming Investor Conference
finance.yahoo.com - February 1 at 10:40 PM |
| Inhibrx Granted Fast Track Designation for INBRX-109 for the Treatment of Unresectable or Metastatic Conventional Chondrosarcoma Patients
finance.yahoo.com - January 13 at 10:13 AM |
 | Inhibrx Inc
reuters.com - December 22 at 10:58 PM |
| Is INBX A Good Stock To Buy Now?
finance.yahoo.com - December 10 at 6:37 PM |
| Industry Analysts Just Made A Dazzling Upgrade To Their Inhibrx, Inc. (NASDAQ:INBX) Revenue Forecasts
nasdaq.com - November 22 at 12:48 PM |
| Inhibrx Reports Financial Results for the Third Quarter 2020 and Announces Amended Loan Agreement with Oxford
finance.yahoo.com - November 13 at 6:21 PM |
 | Inhibrx's INBRX-109 shows encouraging benefit in bone cancer
seekingalpha.com - November 12 at 2:46 PM |
| The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
msn.com - November 12 at 8:46 AM |
| Inhibrx's INBRX- 109 shows encouraging benefit in bone cancer
seekingalpha.com - November 12 at 8:46 AM |
| Inhibrx Announces Positive Interim Results from the Phase 1 Trial of INBRX-109 in Chondrosarcoma Patients
finance.yahoo.com - November 11 at 5:34 PM |
| Inhibrx Announces Participation in Upcoming Investor and Scientific Conferences
finance.yahoo.com - November 5 at 5:01 PM |
| Inhibrx, Inc. (INBX)
finance.yahoo.com - October 19 at 11:48 PM |
| Inhibrx Announces Closing of Initial Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - August 31 at 6:14 PM |
| Oxford Finance Announces $10 Million Credit Facility with Inhibrx, Inc.
finance.yahoo.com - August 31 at 6:14 PM |
